论文题为 “Minocycline upregulates cyclic AMP response element binding protein and brain-derived neurotrophic factor in the ...

Journey Medical Corporation’s DERM share price has surged by 14.32%, which has investors questioning if this is right time to sell.

Journey Medical's future hinges on Emrosi, a new formulation of minocycline for rosacea, showing superior efficacy. Read why ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: Acne Vulgaris Therapeutics Market Size in the 7MM was ~USD 4,256 Million in 2023 and is projected to ...

Effective treatments for people with serious depression who have not been helped by antidepressant medications have novel mechanisms of action.